Critical design parameters to develop biomimetic organ-on-a-chip models for the evaluation of the safety and efficacy of nanoparticles-Reference-Cited by-同舟云学术

Critical design parameters to develop biomimetic organ-on-a-chip models for the evaluation of the safety and efficacy of nanoparticles

Published:2022-12-05 Issue:1 Volume:20 Page:13-30
ISSN:1742-5247
Container-title:Expert Opinion on Drug Delivery
language:en
Short-container-title:Expert Opinion on Drug Delivery

Author:

Abdelkarim Mahmoud¹²,Perez-Davalos Luis²,Abdelkader Yasmin²³,Abostait Amr²,Labouta Hagar I.¹²⁴⁵^ORCID

Affiliation:

1. Biomedical Engineering, University of Manitoba, R3T 5V6, Winnipeg, Manitoba, Canada

2. College of Pharmacy, University of Manitoba, R3E 0T5, Winnipeg, Manitoba, Canada

3. Department of Cell Biology, Biotechnology Research Institute, National Research Centre, 12622, Cairo, Egypt

4. Children’s Hospital Research Institute of Manitoba, R3E 3P4, Winnipeg, Manitoba, Canada

5. Faculty of Pharmacy, Alexandria University, 21521, Alexandria, Egypt

Funder

Natural Sciences and Engineering Research Council

New Frontiers Research Fund

Manitoba Medical Service Foundation and University of Manitoba

Publisher

Informa UK Limited

Subject

Pharmaceutical Science

Link

https://www.tandfonline.com/doi/pdf/10.1080/17425247.2023.2152000

Reference171 articles.

1. (FDA) TUSFaDA. The drug development process: the United States food and drug administration. [Accessed 1 April, 2018]. Available from: https://www.fda.gov/patients/learn-about-drug-and-device-approvals/drug-development-process

2. Diagnosing the decline in pharmaceutical R&D efficiency

3. Breaking Eroom’s Law

4. Estimated Research and Development Investment Needed to Bring a New Medicine to Market, 2009-2018

Cited by 3 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Magnetic nanoparticles fabricated/integrated with microfluidics for biological applications: A review;Biomedical Microdevices;2024-01-25

2. Doxorubicin-mediated cardiac dysfunction: Revisiting molecular interactions, pharmacological compounds and (nano)theranostic platforms;Environmental Research;2023-10

3. Implications of biomimetic nanocarriers in targeted drug delivery;Emergent Materials;2023-01-18